170 related articles for article (PubMed ID: 36178162)
1. Analysis of COVID-19 Pandemic on Supplement Usage and Its Combination with Self-Medication within the State of Arkansas.
Norton JC; Politis MD; Bimali M; Vyas KS; Bircan E; Nembhard WN; Amick BC; Koturbash I
J Diet Suppl; 2023; 20(2):171-198. PubMed ID: 36178162
[TBL] [Abstract][Full Text] [Related]
2. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. Clinical Evidence on the Potential Beneficial Effects of Diet and Dietary Supplements against COVID-19 Infection Risk and Symptoms' Severity.
Pavlidou E; Poulios E; Papadopoulou SK; Fasoulas A; Dakanalis A; Giaginis C
Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390861
[TBL] [Abstract][Full Text] [Related]
5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
6. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
7. Associations between predicted vitamin D status, vitamin D intake, and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity.
Ma W; Nguyen LH; Yue Y; Ding M; Drew DA; Wang K; Merino J; Rich-Edwards JW; Sun Q; Camargo CA; Giovannucci E; Willett W; Manson JE; Song M; Bhupathiraju SN; Chan AT
Am J Clin Nutr; 2022 Apr; 115(4):1123-1133. PubMed ID: 34864844
[TBL] [Abstract][Full Text] [Related]
8. Knowledge, Attitudes, and Practices Related to Dietary Supplementation, before and during the COVID-19 Pandemic: Findings from a Cross-Sectional Survey in the Lebanese Population.
Mohsen H; Yazbeck N; Al-Jawaldeh A; Bou Chahine N; Hamieh H; Mourad Y; Skaiki F; Salame H; Salameh P; Hoteit M
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444605
[TBL] [Abstract][Full Text] [Related]
9. Associations between self-reported symptoms of SARS-CoV-2 and dietary supplement use over the previous year during the first pandemic wave.
Ellis A; Bui C; Ferguson C; Azarmanesh D; Park HA
J Nutr Sci; 2023; 12():e4. PubMed ID: 36721723
[TBL] [Abstract][Full Text] [Related]
10. Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic.
Brown JD; Vouri SM; Manini TM
Res Social Adm Pharm; 2021 Aug; 17(8):1478-1482. PubMed ID: 33221267
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
12. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
Xu Y; Baylink DJ; Chen CS; Reeves ME; Xiao J; Lacy C; Lau E; Cao H
J Transl Med; 2020 Aug; 18(1):322. PubMed ID: 32847594
[TBL] [Abstract][Full Text] [Related]
13. Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
Wright JK; Tan DHS; Walmsley SL; Hulme J; O'Connor E; Snider C; Cheng I; Chan AK; Borgundvaag B; McLeod S; Gollob MH; Clarke RJ; Dresser L; Haji F; Mazzulli T; Mubareka S; Jüni P; Lee D; Tomlinson G; Kain KC; Landes M
Trials; 2020 Jul; 21(1):647. PubMed ID: 32665039
[TBL] [Abstract][Full Text] [Related]
14. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
15. Association between bisphosphonate use and COVID-19 related outcomes.
Thompson J; Wang Y; Dreischulte T; Barreiro O; Gonzalez RJ; Hanč P; Matysiak C; Neely HR; Rottenkolber M; Haskell T; Endres S; von Andrian UH
Elife; 2023 Aug; 12():. PubMed ID: 37534876
[TBL] [Abstract][Full Text] [Related]
16. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
Hoşgelen EI; Alptekin K
Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
[TBL] [Abstract][Full Text] [Related]
17. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
Hoşgelen EI; Alptekin K
Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
[TBL] [Abstract][Full Text] [Related]
18. Vitamins and minerals: A means for surviving the COVID-19 pandemic or just a myth?
El Sabbagh E; El-Sayed M; Elbaz T
J Infect Dev Ctries; 2022 May; 16(5):782-786. PubMed ID: 35656948
[TBL] [Abstract][Full Text] [Related]
19. Myth Busters: Dietary Supplements and COVID-19.
Adams KK; Baker WL; Sobieraj DM
Ann Pharmacother; 2020 Aug; 54(8):820-826. PubMed ID: 32396382
[TBL] [Abstract][Full Text] [Related]
20. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial.
Lother SA; Abassi M; Agostinis A; Bangdiwala AS; Cheng MP; Drobot G; Engen N; Hullsiek KH; Kelly LE; Lee TC; Lofgren SM; MacKenzie LJ; Marten N; McDonald EG; Okafor EC; Pastick KA; Pullen MF; Rajasingham R; Schwartz I; Skipper CP; Turgeon AF; Zarychanski R; Boulware DR
Can J Anaesth; 2020 Sep; 67(9):1201-1211. PubMed ID: 32383125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
